The treatment of A549 cells with ABN-B increased the levels of cleaved PARP and caspase-7, but decreased the expression level of anti-apoptotic Bcl-2 protein in a concentration-dependent manner (Figure 3C), indicating that this compound may have the ability to induce apoptosis in human lung cancer cells. Here, BCL2 is linked to lung cancer.